DETERMINATION OF DERMATOLOGY LIFE QUALITY INDEX IN CHRONIC PLAQUE PSORIASIS IN RURAL HEALTH CENTRE

Main Article Content

Dr. Pradeepa Ramamurthy
Dr P.K Kaviarasan

Keywords

.

Abstract

Psoriasis is a multifactorial, genetically determined common   papulosquamous disorder which affects skin, hair, nail and musculoskeletal system affecting 1 to 2 % of the population[1]. It has been recognized as a psycho dermatological disorder since various forms of stress and psychological conditions are associated with its exacerbation.


Dermatology life quality index The DLQI consists 10 questions with simple tick b++ox answers scored from 0-3. The mean answer time is two minute.Use of DLQI has allowed assessment of disability of patients with psoriasis. . The poorer DLQI score for adherence (compliance) with topical therapy, mean QOL is severely impaired psoriasis has significant negative impact on patients Health Related Quality of Life (HRQOL)[2]. Scoring of each question is as follows. Very much -3..A lot-2. A little-1 Not at all-0. Not relevant -0. Meaning of DLQI 0-1 no effect at all on patient life.2-5 small effect on patient life.6-10 moderate effect on patient life.11-20 very large effect on patient life.21-30 extremely large effect on patient life.

Abstract 221 | PDF Downloads 11

References

1. Farberr, E, Nall ML., The Natural History of Psoriasis .Dermatologica,1974;148:1-18.
2. Dogra S, Yadav. S, Psoriasis in India: Prevalence and pattern Indian J Dermatology.Venerol Leprol.2013;79:1-9.
3. Mahajan ,R,Handa,S.Pathophysiology of Psoriasis .Indian J Dermatol. Venerol Leprol.2013;79:1-9.
4. Burns , Tony , Breathnach,Stephen; Cox,Neil, Griffiths, Christopher, Rook Text book of Dermatology,8th Edition.
5. Kaplan and Sadock ,Comprehensive Text Book of Psychiatry, 9 th Edition.
6. Quality of life in Patients with Psoriasis.Monali J Bhonsle,Amitt Kulkarani, Sterin R Feldman ,June2006.
7. Aurangabadkar SJ.Comorbidities in Psoriasis.Indian J Dermatol Vernon Leprol.2013;79:10-7.
8. Kumar S, Kachhawhad, Koolwal. GD, Gehlot S, Awasthi .A Psychiatric Morbidity In Psoriasis Patients: A Pilot Study.Indian J Dermatol Venerol Leprol.2013;77:625.
9 . Pearce Dj,Singh S Balakrishnan R,Kulkarni,A Fleischer AB,Feldman SR, The negative Impact Of Psoriasis in the Work Place.J Dermatology Treat.2006;17:24-28.
10. Fortune DG,Richards HL, Griffiths CE,Psychological factors in psoriasis: Consequences , mechanism, and interventions.Dermatol Clinical 2005;23:681-699.
11. Gupta MA,Schork NJ,Gupta Ak,Kirby S,Ellis CN,Ellis CN, suicidal ideation in Psoraisis.Int.J.Dermatol.1993;32:188-190.
12. Gimburg IH,Link BG,Psychological Consequences of Rejection and Stigma Feelings in Psoriasis Patients.Int J Dermatol.1993;32:57-591.
13. Jowetts,Ryan T, Skin disease and handicap:An analysis of Impacr of Skin condition.Soc.SCI.Med.1985;20:4425-429.
14. Sujay Khandpur,Neetu Bhari,New Targeted Therapies in Psoriasis.January2013.
15. Fortune DG, Richard HL,Griffiths CE: Psychological Factors in psoriasis:consequences, Mechanisms, and interventions.Dermatolchin 2005,23:681-694.
16.Ginsburg IH, Link BG: Psychological consequences of rejection and stigma feelings In feelings in psoriasis patients.Int J Dermatology 1993,32:587-59.
17.Ginsburg IH,Link BG :Psychological consequences of rejection and stigma feelings in Psoriasis patients.Int J dermatology 1993,32:587-59.
18. Lowe N ,Lebsack M, Wandel .Psoriasis patients show improved quality of life when treated with entanercept. Löwen, Lebsack M.wandel.Quality of life when treated with Etanercept Ann Dermatol venerol 2002;129;15762A broad spectrum of patients with psoriasis benefit from a alefacept therapy.
19. Katugumpola R,Lewis VJ.Finlay AY. A review of the Dermatology life quality index in assessing the efficiency of biological treatment of psoriasis BJD2006;155(snppl)134.
20. Lewis V, Finlay ten years of experience of dermatology life quality I dex(DLQI).J invest Dersymproc 2004;9:169-80.
21. Lewis-Jones Ms , Finlay AY. The children dermatology life quality index(DLQI):initial Validation and practical use for Br J Dermatol 1995,132;942-9.
22. Houghboy ,Thomas Cl, Harrison MA, Salem MS,finally AY translating the sciences of quality of life into practice ,What do the DLQI scores mean Br J Dermatology 2004;151.
23. Lewis V, Finlay AY 20 years experience of psoriasis disability index under pol Br. Dermatol;151(suppl68):50-1.
24..Salek Ms Finlay Ay .Quality of life in patients with severe psoriasis receiving cyclosporine: A multicentric study J Applied therap Res 2003;4:3-10.
25.Morgan M, Mccreedy R, Sinipson J,Hay RJ.Dermatology quality of life scales : A measure of impact of skin disease.Br J Dermatol 1997;136,202-6.